Research
Hormonal
NuSH-based therapies, including semaglutide and tirzepatide, are highly effective for the treatment of overweight (BMI >27 kg·m−2 with a health condition) and obesity (BMI >30 kg·m−2), with average weight loss exceeding that achieved with lifestyle modification alone.
Healthcare providers should consider prescribing NuSH-based therapies for patients struggling with overweight and obesity.
StrongSupportsmedium confidence
These medications have been shown to be highly effective for the treatment of overweight (body mass index (BMI) >27 kg·m−2 with a concomitant health condition) and obesity (BMI over 30 kg·m−2), with the average weight loss exceeding what is typically achieved with lifestyle modification alone.
Why this rating
The claim is based on the effectiveness of approved pharmacotherapy for obesity.
Source
Contemporary Treatments for Obesity: Physical Activity in the Context of Antiobesity Medications
John M. Jakicic et al. · Translational Journal of the American College of Sports Medicine · 2024
reviewCited 8×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →